Product Images Zortress

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Zortress NDC 0078-0422 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Zortress structural formula of everolimus is (1R, 9S, 12S, 15R, 16E, 18R, 19R, 21R, 23S, 24E, 26E, 28E, 30S, 32S, 35R)-1, 18-dihydroxy-12 -{(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl}-19,30-dimethoxy-15, 17, 21, 23, 29, 35-hexamethyl-11, 36-dioxa-4-aza-tricyclo[30.3.1.04,9] hexatriaconta-16,24,26,28-tetraene-2, 3,10,14,20-pentaone. - zortress 01

Zortress structural formula of everolimus is (1R, 9S, 12S, 15R, 16E, 18R, 19R, 21R, 23S, 24E, 26E, 28E, 30S, 32S, 35R)-1, 18-dihydroxy-12 -{(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl}-19,30-dimethoxy-15, 17, 21, 23, 29, 35-hexamethyl-11, 36-dioxa-4-aza-tricyclo[30.3.1.04,9] hexatriaconta-16,24,26,28-tetraene-2, 3,10,14,20-pentaone. - zortress 01

PRINCIPAL DISPLAY PANELPackage Label – 0.25 mgRx Only NDC 0078-0417-20Zortress® (everolimus) Tablets - zortress 02

PRINCIPAL DISPLAY PANELPackage Label – 0.25 mgRx Only	NDC 0078-0417-20Zortress® (everolimus) Tablets - zortress 02

This appears to be a product description for a medication called "& ZORTRESS (Everolimus) Tablets" in two different languages. The dosage is listed as 0.25mg per tablet and there is some information about the packaging. However, there is a lot of missing information and unclear formatting, making it difficult to understand the full context of the text.*

PRINCIPAL DISPLAY PANELPackage Label – 0.5 mgRx Only NDC 0078-0414-20Zortress® (everolimus) Tablets - zortress 03

PRINCIPAL DISPLAY PANELPackage Label – 0.5 mgRx Only	NDC 0078-0414-20Zortress® (everolimus) Tablets - zortress 03

Wooomsastez Fonly (everolimus) Tablets are available in 0.5 mg per tablet strength.*

PRINCIPAL DISPLAY PANELPackage Label – 0.75 mgRx Only NDC 0078-0415-20Zortress® (everolimus) Tablets - zortress 04

PRINCIPAL DISPLAY PANELPackage Label – 0.75 mgRx Only	NDC 0078-0415-20Zortress® (everolimus) Tablets - zortress 04

The text is related to a medication called Everolimus available in the form of tablets. No further information is available.*

Figure 1. Mean and 95% CI of eGFR (MDRD 4) [mL/min/1.73m2] by Visit Window and Treatment after Liver Transplantation (ITT population 24 Month Analysis)* - zortress 05

Figure 1. Mean and 95% CI of eGFR (MDRD 4) [mL/min/1.73m2] by Visit Window and Treatment after Liver Transplantation (ITT population 24 Month Analysis)* - zortress 05

This text provides information about a medical test result. The GFR (glomerular filtration rate) was measured using the MDRD 4 formula, and the result was 110 mL/min/1.73m^2. The remaining text indicates visit windows and treatment groups for a clinical trial, and is not relevant to the medical test result.*

zortress 06

zortress 06

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.